Trade MannKind Corp - MNKD CFD

Trading Conditions

• Type: CFD
• Spread: 0.03
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 2.51
• Open: 2.47
• 1-Year Change: -53.13%
• Day's Range: 2.41 - 2.5

What is MannKind Corp (MNKD)?

MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products for patients with chronic diseases. The company specializes in inhalation technology and drug delivery systems, aiming to improve the administration and efficacy of treatments. MannKind's research and development efforts primarily target diabetes and other serious medical conditions, utilizing proprietary technologies to enhance drug absorption and patient compliance. The company operates within the pharmaceutical and biotechnology sectors, collaborating with various partners to advance its pipeline and expand its product offerings. MannKind's business model includes both internal development and external partnerships to bring innovative therapies to market.

MannKind Corp Stock Price Today: Live Overview

The price today is shaped by ongoing trading dynamics, with MannKind Corp currently at $2.49. The intraday range has been between $2.4 and $2.52, reflecting a daily change of 0%.

FAQ: MannKind Corp (MNKD)

What is the current price of MNKD stock?

MannKind Corp is currently trading at $2.49.

Does MNKD pay dividends?

MannKind Corp pays dividends via cash distributions (if applicable).

Does MNKD have a formal corporate presence or regional headquarters in the UAE?

MannKind Corp does not have an official regional office or registered presence in the UAE and operates via partners or distributors.

What is MNKD best known for?

The company is most famous for its development of inhaled therapeutic products, including Afrezza.

What assets are typically shown together with MNKD?

Commonly shown alongside MNKD: Genprex, Inc., ACADIA Pharmaceuticals Inc, Invivyd Inc.